Franco Berrino

Author PubWeight™ 210.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008 7.18
2 Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCISproject): an epidemiological study. Lancet 2004 5.64
3 Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet 2009 5.14
4 Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst 2005 4.45
5 Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003 3.89
6 Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006 3.41
7 Incidence of hematologic malignancies in Europe by morphologic subtype: results of the HAEMACARE project. Blood 2010 3.21
8 Body size and breast cancer risk: findings from the European Prospective Investigation into Cancer And Nutrition (EPIC). Int J Cancer 2004 2.96
9 Fruit and vegetable intake and the risk of stomach and oesophagus adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST). Int J Cancer 2006 2.89
10 Women's perception of the benefits of mammography screening: population-based survey in four countries. Int J Epidemiol 2003 2.79
11 Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA 2005 2.76
12 Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study. BMJ 2010 2.66
13 Serum sex steroids in premenopausal women and breast cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2005 2.53
14 Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort. Int J Cancer 2005 2.32
15 Childhood cancer survival trends in Europe: a EUROCARE Working Group study. J Clin Oncol 2005 2.02
16 Metabolic syndrome as a prognostic factor for breast cancer recurrences. Int J Cancer 2006 2.00
17 Sex hormone levels, breast cancer risk, and cancer receptor status in postmenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2009 1.99
18 Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. BMJ 2011 1.94
19 Fasting glucose is a risk factor for breast cancer: a prospective study. Cancer Epidemiol Biomarkers Prev 2002 1.83
20 Dietary glycemic load and index and risk of coronary heart disease in a large italian cohort: the EPICOR study. Arch Intern Med 2010 1.77
21 Time trends of breast cancer survival in Europe in relation to incidence and mortality. Int J Cancer 2006 1.71
22 Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women. J Clin Endocrinol Metab 2006 1.71
23 Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2008 1.65
24 Progestins and progesterone in hormone replacement therapy and the risk of breast cancer. J Steroid Biochem Mol Biol 2005 1.65
25 Childhood cancer survival in Europe and the United States. Cancer 2002 1.59
26 Plasma phospholipid fatty acid profiles and their association with food intakes: results from a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008 1.57
27 Comparative cancer survival information in Europe. Eur J Cancer 2009 1.56
28 No association of consumption of animal foods with risk of ovarian cancer. Cancer Epidemiol Biomarkers Prev 2007 1.55
29 Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006 1.55
30 Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study. Breast Cancer Res Treat 2007 1.55
31 Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women. Int J Cancer 2004 1.52
32 Breast cancer risk in relation to abortion: Results from the EPIC study. Int J Cancer 2006 1.51
33 Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007 1.49
34 Survival from rare cancer in adults: a population-based study. Lancet Oncol 2006 1.49
35 Meat, eggs, dairy products, and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Am J Clin Nutr 2009 1.45
36 Circulating inflammation markers and risk of epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2011 1.44
37 Anthropometric measures, endogenous sex steroids and breast cancer risk in postmenopausal women: a study within the EPIC cohort. Int J Cancer 2006 1.43
38 Breast carcinoma survival in Europe and the United States. Cancer 2004 1.43
39 Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr 2007 1.40
40 Physical activity and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2006 1.38
41 Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2008 1.37
42 Adiposity, hormone replacement therapy use and breast cancer risk by age and hormone receptor status: a large prospective cohort study. Breast Cancer Res 2012 1.37
43 Obesity, inflammatory markers, and endometrial cancer risk: a prospective case-control study. Endocr Relat Cancer 2010 1.35
44 Alcohol intake and breast cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2007 1.33
45 Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004 1.33
46 Pleural mesothelioma incidence in Europe: evidence of some deceleration in the increasing trends. Cancer Causes Control 2003 1.32
47 Hepatocellular carcinoma: trends of incidence and survival in Europe and the United States at the end of the 20th century. Am J Gastroenterol 2007 1.30
48 Childhood leukemia and road traffic: A population-based case-control study. Int J Cancer 2004 1.27
49 Dietary fat and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition. Am J Clin Nutr 2008 1.27
50 Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007 1.27
51 A molecular epidemiology project on diet and cancer: the EPIC-Italy Prospective Study. Design and baseline characteristics of participants. Tumori 2004 1.26
52 Diet in the Italian EPIC cohorts: presentation of data and methodological issues. Tumori 2004 1.26
53 The association between diet and serum concentrations of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3 in the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2009 1.24
54 Circulating levels of insulin-like growth factor-I and risk of ovarian cancer. Int J Cancer 2002 1.24
55 Intake of fruits and vegetables and risk of cancer of the upper aero-digestive tract: the prospective EPIC-study. Cancer Causes Control 2006 1.23
56 Breast cancer survival in the US and Europe: a CONCORD high-resolution study. Int J Cancer 2012 1.23
57 Cigarette smoking and risk of histological subtypes of epithelial ovarian cancer in the EPIC cohort study. Int J Cancer 2011 1.22
58 Endogenous sex hormones and subsequent breast cancer in premenopausal women. Int J Cancer 2004 1.21
59 Urinary 6-Sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2010 1.20
60 Plasma folate, related genetic variants, and colorectal cancer risk in EPIC. Cancer Epidemiol Biomarkers Prev 2010 1.18
61 Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer. J Clin Oncol 2008 1.17
62 Circulating levels of sex steroid hormones and risk of ovarian cancer. Int J Cancer 2003 1.17
63 Haplotype analysis of the HSD17B1 gene and risk of breast cancer: a comprehensive approach to multicenter analyses of prospective cohort studies. Cancer Res 2006 1.16
64 Tobacco smoke and bladder cancer--in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006 1.16
65 Fruits and vegetables and lung cancer: Findings from the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2004 1.16
66 Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011 1.15
67 Dietary patterns and risk of breast cancer in the ORDET cohort. Cancer Epidemiol Biomarkers Prev 2004 1.14
68 Combination of DNA repair gene single nucleotide polymorphisms and increased levels of DNA adducts in a population-based study. Cancer Epidemiol Biomarkers Prev 2003 1.14
69 Ten-year survival and risk of relapse for testicular cancer: a EUROCARE high resolution study. Eur J Cancer 2007 1.13
70 Vitamin D receptor and calcium sensing receptor polymorphisms and the risk of colorectal cancer in European populations. Cancer Epidemiol Biomarkers Prev 2009 1.13
71 Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007 1.12
72 Dietary intakes of omega-6 and omega-3 polyunsaturated fatty acids and the risk of breast cancer. Int J Cancer 2009 1.11
73 Dietary glycemic index, glycemic load, and the risk of breast cancer in an Italian prospective cohort study. Am J Clin Nutr 2007 1.10
74 A prospective study of dietary selenium intake and risk of type 2 diabetes. BMC Public Health 2010 1.09
75 A priori-defined dietary patterns are associated with reduced risk of stroke in a large Italian cohort. J Nutr 2011 1.08
76 Evidence against the proposition that "UK cancer survival statistics are misleading": simulation study with National Cancer Registry data. BMJ 2011 1.06
77 Reproductive factors and risk of hormone receptor positive and negative breast cancer: a cohort study. BMC Cancer 2013 1.05
78 Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 2007 1.05
79 Lifestyle and breast cancer recurrences: the DIANA-5 trial. Tumori 2012 1.04
80 Common and country-specific dietary patterns in four European cohort studies. J Nutr 2003 1.04
81 Prospective study on the role of glucose metabolism in breast cancer occurrence. Int J Cancer 2011 1.03
82 Serum IGF-I, its major binding protein (IGFBP-3) and epithelial ovarian cancer risk: the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007 1.02
83 A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Hum Biol 2010 1.02
84 Occupation and larynx and hypopharynx cancer: an international case-control study in France, Italy, Spain, and Switzerland. Cancer Causes Control 2003 1.01
85 Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis. Cancer Epidemiol Biomarkers Prev 2008 1.00
86 Risk of endometrial cancer in relationship to cigarette smoking: results from the EPIC study. Int J Cancer 2007 0.99
87 High fasting blood glucose and obesity significantly and independently increase risk of breast cancer death in hormone receptor-positive disease. Eur J Cancer 2013 0.99
88 C-reactive protein and ovarian cancer: a prospective study nested in three cohorts (Sweden, USA, Italy). Cancer Causes Control 2009 0.99
89 Erythrocyte membrane phospholipid composition as a biomarker of dietary fat. Ann Nutr Metab 2005 0.99
90 Trends in childhood cancer incidence in Europe, 1970-99. Lancet 2005 0.98
91 Active and passive cigarette smoking and breast cancer risk: results from the EPIC cohort. Int J Cancer 2014 0.98
92 The contribution of risk factors to the higher incidence of invasive and in situ breast cancers in women with higher levels of education in the European prospective investigation into cancer and nutrition. Am J Epidemiol 2010 0.98
93 Associations between dietary pattern and lifestyle, anthropometry and other health indicators in the elderly participants of the EPIC-Italy cohort. Nutr Metab Cardiovasc Dis 2006 0.98
94 Patient survival for all cancers combined as indicator of cancer control in Europe. Eur J Public Health 2008 0.97
95 Polymorphisms in fatty-acid-metabolism-related genes are associated with colorectal cancer risk. Carcinogenesis 2009 0.96
96 Total antioxidant capacity of the diet is associated with lower risk of ischemic stroke in a large Italian cohort. J Nutr 2010 0.96
97 Predictions of survival up to 10 years after diagnosis for European women with breast cancer in 2000-2002. Int J Cancer 2012 0.96
98 Polymorphisms in metabolic genes related to tobacco smoke and the risk of gastric cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006 0.95
99 Italian Mediterranean Index and risk of colorectal cancer in the Italian section of the EPIC cohort. Int J Cancer 2012 0.94
100 Fat and protein intake and subsequent breast cancer risk in postmenopausal women. Nutr Cancer 2002 0.94
101 Macronutrient composition of the diet and prospective weight change in participants of the EPIC-PANACEA study. PLoS One 2013 0.94
102 Plasma testosterone and prognosis of postmenopausal breast cancer patients. J Clin Oncol 2007 0.93
103 A dietary pattern rich in olive oil and raw vegetables is associated with lower mortality in Italian elderly subjects. Br J Nutr 2007 0.93
104 Cancer control in Europe: a proposed set of European cancer health indicators. Eur J Public Health 2003 0.93
105 Salad vegetables dietary pattern protects against HER-2-positive breast cancer: a prospective Italian study. Int J Cancer 2007 0.92
106 Metformin, diet and breast cancer: an avenue for chemoprevention. Cell Cycle 2009 0.92
107 Human papillomavirus in HNSCC: a European epidemiologic perspective. Hematol Oncol Clin North Am 2008 0.92
108 Fasting blood glucose and long-term prognosis of non-metastatic breast cancer: a cohort study. Breast Cancer Res Treat 2013 0.92
109 Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer. Cancer Epidemiol 2012 0.92
110 Physical activity and risk of breast cancer overall and by hormone receptor status: the European prospective investigation into cancer and nutrition. Int J Cancer 2012 0.90
111 Factors associated with inflammation markers, a cross-sectional analysis. Cytokine 2011 0.89
112 Do pre-diagnostic drinking habits influence breast cancer survival? Tumori 2011 0.89
113 Body mass index in relation to ovarian cancer: a multi-centre nested case-control study. Int J Cancer 2002 0.89
114 Consumption of meat and fish and risk of lung cancer: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Causes Control 2011 0.89
115 Fruits and vegetables and prostate cancer: no association among 1104 cases in a prospective study of 130544 men in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2004 0.89
116 Menopausal hormone therapy and risk of ovarian cancer in the European prospective investigation into cancer and nutrition. Cancer Causes Control 2011 0.89
117 Yogurt consumption and risk of colorectal cancer in the Italian European prospective investigation into cancer and nutrition cohort. Int J Cancer 2011 0.89
118 DNA repair polymorphisms and the risk of stomach adenocarcinoma and severe chronic gastritis in the EPIC-EURGAST study. Int J Epidemiol 2008 0.88
119 Menopausal hormone therapy and risk of colorectal cancer in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2011 0.88
120 Vitamins B2 and B6 and genetic polymorphisms related to one-carbon metabolism as risk factors for gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2010 0.88
121 Dietary patterns and breast cancer risk: results from three cohort studies in the DIETSCAN project. Cancer Causes Control 2005 0.87
122 IGF-I, IGFBP-3 and breast cancer in young women: a pooled re-analysis of three prospective studies. Eur J Cancer Prev 2005 0.87
123 Correlates of age at natural menopause in the cohorts of EPIC-Italy. Tumori 2004 0.87
124 Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study. Cancer Epidemiol Biomarkers Prev 2005 0.87
125 Effect of different doses of metformin on serum testosterone and insulin in non-diabetic women with breast cancer: a randomized study. Clin Breast Cancer 2012 0.87
126 Red meat, dietary nitrosamines, and heme iron and risk of bladder cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Epidemiol Biomarkers Prev 2011 0.87
127 Fruit and vegetables consumption and breast cancer risk: the EPIC Italy study. Breast Cancer Res Treat 2012 0.86
128 Dietary intake of iron, heme-iron and magnesium and pancreatic cancer risk in the European prospective investigation into cancer and nutrition cohort. Int J Cancer 2012 0.86
129 Toenail selenium as biomarker: reproducibility over a one-year period and factors influencing reproducibility. J Trace Elem Med Biol 2003 0.85
130 No association between polymorphisms in CYP2E1, GSTM1, NAT1, NAT2 and the risk of gastric adenocarcinoma in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev 2006 0.85
131 Ecological-level associations between highly processed food intakes and plasma phospholipid elaidic acid concentrations: results from a cross-sectional study within the European prospective investigation into cancer and nutrition (EPIC). Nutr Cancer 2011 0.85
132 Varicose veins of the lower limbs and venous capacitance in postmenopausal women: relationship with obesity. J Vasc Surg 2002 0.83
133 Determinants of exposure to environmental tobacco smoke in 21,588 Italian non-smokers. Tumori 2004 0.83
134 Dietary glycemic load and glycemic index and risk of cerebrovascular disease in the EPICOR cohort. PLoS One 2013 0.83
135 Influence of morphology on survival for non-Hodgkin lymphoma in Europe and the United States. Eur J Cancer 2008 0.83
136 Serum follicle-stimulating hormone and risk of epithelial ovarian cancer in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2003 0.83
137 Prostate cancer treatment in Europe at the end of 1990s. Acta Oncol 2009 0.83
138 The intake of grain fibers modulates cytokine levels in blood. Biomarkers 2011 0.83
139 Rebuttal to editorial saying cancer survival statistics are misleading. BMJ 2011 0.82
140 Occupation and risk of lymphoma: a multicentre prospective cohort study (EPIC). Occup Environ Med 2010 0.81
141 Circulating prolactin levels and risk of epithelial ovarian cancer. Cancer Causes Control 2013 0.81
142 Late outcomes of colorectal cancer treatment: a FECS-EUROCARE study. J Cancer Surviv 2007 0.81
143 Testosterone and biological characteristics of breast cancers in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2009 0.81
144 Endogenous sex steroids in premenopausal women and risk of breast cancer: the ORDET cohort. Breast Cancer Res 2013 0.81
145 Oral contraceptive use and BRCA penetrance: a case-only study. Cancer Epidemiol Biomarkers Prev 2009 0.80
146 The Italian surveillance system for occupational cancers: characteristics, initial results, and future prospects. Am J Ind Med 2006 0.80
147 Haplotype-based analysis of common variation in the acetyl-coA carboxylase alpha gene and breast cancer risk: a case-control study nested within the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 2007 0.80
148 Metformin decreases circulating androgen and estrogen levels in nondiabetic women with breast cancer. Clin Breast Cancer 2013 0.80
149 Circulating enterolactone and risk of endometrial cancer. Int J Cancer 2006 0.80
150 Contrasts in cancer prevalence in Connecticut, Iowa, and Utah. Cancer 2002 0.78
151 Risk of ovarian cancer in relation to prediagnostic levels of C-peptide, insulin-like growth factor binding proteins-1 and -2 (USA, Sweden, Italy). Cancer Causes Control 2003 0.78
152 A plant food-based diet modifies the serum beta-sitosterol concentration in hyperandrogenic postmenopausal women. J Nutr 2003 0.78
153 Serum levels of IGF-I and BRCA penetrance: a case control study in breast cancer families. Fam Cancer 2011 0.78
154 Serum fructosamine and subsequent breast cancer risk: a nested case-control study in the ORDET prospective cohort study. Cancer Epidemiol Biomarkers Prev 2005 0.78
155 Exercise training reduces high mobility group box-1 protein levels in women with breast cancer: findings from the DIANA-5 study. Monaldi Arch Chest Dis 2014 0.77
156 Circulating sex hormones and tumor characteristics in postmenopausal breast cancer patients. A cross-sectional study. Int J Biol Markers 2011 0.77
157 Should we use incidence, survival or mortality to assess breast cancer trends in European women? Nat Clin Pract Oncol 2006 0.77
158 Androgen receptors and serum testosterone levels identify different subsets of postmenopausal breast cancers. BMC Cancer 2012 0.77
159 [Soft tissue sarcomas in Mantua: epidemiological evidence and perspectives for environmental remediation]. Epidemiol Prev 2005 0.77
160 Plasma retinol and prognosis of postmenopausal breast cancer patients. Cancer Epidemiol Biomarkers Prev 2009 0.77
161 Re: Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women. J Natl Cancer Inst 2007 0.77
162 Strategies for cancer control in Italy. Tumori 2007 0.77
163 Cereal fiber intake may reduce risk of gastric adenocarcinomas: the EPIC-EURGAST study. Int J Cancer 2007 0.77
164 Oophorectomy and breast cancer in BRCA mutation carriers--letter. Cancer Epidemiol Biomarkers Prev 2012 0.75
165 Circulating soluble Fas levels and risk of ovarian cancer. BMC Cancer 2003 0.75
166 Progestagens use before menopause and breast cancer risk according to histology and hormone receptors. Cancer Epidemiol Biomarkers Prev 2008 0.75
167 [Weapons of mass destruction]. Epidemiol Prev 2014 0.75
168 [Drink more milk...]. Epidemiol Prev 2014 0.75
169 Estimate of the penetrance of BRCA mutation and the COS software for the assessment of BRCA mutation probability. Fam Cancer 2015 0.75
170 [Active and passive smoking: two sides of the same medal]. Epidemiol Prev 2005 0.75
171 [Campaign «Asbestos free»]. Epidemiol Prev 2012 0.75
172 [Hundreds of workers killed by VCM]. Epidemiol Prev 2006 0.75
173 Recent trends of cancer mortality in Romanian adults: mortality is still increasing, although young adults do better than the middle-aged and elderly population. Eur J Cancer Prev 2013 0.75
174 Nutritional advice to breast cancer survivors. Support Care Cancer 2009 0.75
175 Physical activity in the EPIC-Italy centers. Tumori 2004 0.75